Learn more about whether Inari Medical, Inc. or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Learn more about whether Bausch + Lomb Corporation or Inari Medical, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

We recently published an article titled Why These 10 Small-Cap Stocks Are Skyrocketing. In this article, we are going to take ...

We recently compiled a list of the 10 Hottest Mid-Cap Stocks So Far in 2025. In this article, we are going to take a look at ...

Stryker Corporation (NYSE:SYK), a leading player in the medical technology industry with a substantial market capitalization of $149 billion, has been making waves with its strong financial ...

Inari Medical Inc (NARI) stock saw a modest uptick, ending the day at $79.74 which represents a slight increase of $0.28 or 0.35% from the prior close of $79.46. The stock opened at $79.54 and touched ...

We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at ...

On Tuesday, Inari Medical Inc (NARI) stock saw a decline, ending the day at $79.5 which represents a decrease of $-0.05 or -0.06% from the prior close of $79.55. The stock opened at $79.54 and touched ...

Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the ...

Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired by Stryker proved to be true, with the companies announcing the deal after ...

Inari Medical (TASE:PMCN) Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the $4.68 billion medical device company.